BKJ’s SI was 15,800 shares in September as released by FINRA. While in the same Quarter Previous year, the Actual EPS was $0.77. The value of the position overall is up by 109,110.3%. Steinberg Asset Mgmt has 0.51% invested in Texas Pacific Land Trust (NYSE:TPL) for 10,240 shares. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Penserra Capital Management LLC now owns 1,959 shares of the biopharmaceutical company’s stock valued at $105,000 after buying an additional 956 shares in the last quarter. The company’s past year sales total was 4.92 Million. The company has market cap of $103.28 billion. Exane Asset Management augmented its ownership by buying 34,226 shares an increase of 6.6%. Trading was heavy with 6,976K shares changing hands in the last trading session. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since September 19, 2016 and is downtrending. It has underperformed by 39.89% the S&P500. The company has market cap of $238.80 million. It has a 22.95 P/E ratio. The Company, through the Bank, conducts a traditional commercial banking business, accepting deposits from the general public, including individuals, businesses, non-profit organizations and governmental units. This defines the most likely future of the stock price of Bristol-Myers Squibb Company.
On 8/3/2016 Bristol-Myers Squibb Company announced a quarterly dividend of $0.38 2.02% with an ex dividend date of 10/5/2016 which will be payable on 11/1/2016. Shareholders of record on Friday, October 6th will be paid a $0.39 dividend. Its down 0.03, from 0.98 in 2016Q3.
Other large investors have also recently bought and sold shares of the company. Gilman Hill Asset Limited Company holds 0.35% or 16,316 shares in its portfolio. National Bank Of America Corporation De has invested 0% of its portfolio in Sigma Designs Inc (NASDAQ:SIGM). Girard Ltd reported 35,697 shares. Proshare Advsrs Limited Liability reported 10,145 shares stake.
Edgestream Partners acquired a new position in stocks of Bristol-Myers Squibb Company (NYSE:BMY) through out the 1st period, based on the latest 13F document with the SEC (SEC). Bb&T Secs Limited Co holds 681,179 shares or 0.54% of its portfolio. With that said, researchers took a deep dive into the hotly debated question: is it too late to buy Bristol-Myers Squibb Company (NYSE:BMY). 25,535 were reported by Agran Libbie. Deprince Race Zollo stated it has 5,500 shares or 0.03% of all its holdings. The biopharmaceutical company reported $0.74 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.01.
The current consensus rating on Bristol-Myers Squibb Company (NYSE:BMY) is Hold (Score: 2.44) with a consensus target price of $62.14 per share, a potential 1.25% downside. 20 were accumulated by Alexandria Cap Ltd Liability.
Bristol-Myers Squibb (NYSE BMY) opened at 62.93 on Monday. Chesapeake Asset Mngmt Ltd holds 0.24% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 4,718 shares. Deutsche Bank AG set a $55.00 target price on Bristol-Myers Squibb and gave the company a hold rating in a research report on Monday, July 17th. Therefore 32% are positive. July 28 investment analysts at Leerink Swann kept the company rating at “Outperform” and lowered the price target to $61.00 from $77.00.
Bristol-Myers Squibb Company, launched on August 11, 1933, is involved in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Jefferies has “Hold” rating and $65 target.
Many investment analysts have quite recently weighed in on BMY Stocks. The company was upgraded on Friday, January 22 by Berenberg. Blume Capital Management Inc. raised its position in shares of Bristol-Myers Squibb by 2.4% in the third quarter. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. The firm has “Buy” rating by UBS given on Friday, April 29. The firm earned “Equal-Weight” rating on Friday, August 5 by Morgan Stanley. Cowen & Co maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Monday, August 14. Zeke Advisors Llc holds 0.2% in Bristol-Myers Squibb Co (NYSE:BMY) or 12,875 shares.
Private Management Group Inc decreased Kapstone Paper & Packaging C (NYSE:KS) stake by 423,961 shares to 814,841 valued at $17.97 million in 2016Q4. It also reduced its holding in Ishares Tr (MUB) by 30,137 shares in the quarter, leaving it with 215,784 shares, and cut its stake in Select Sector Spdr Tr (XLE).